B1 Other refereed article (e.g., editorial, letter, comment) in a scientific journal
Physician global assessment in rheumatoid arthritis—is there any logic?
Authors: Jäppinen, Katriina; Muilu, Paula; Autio, Reija; Kuusalo, Laura; Sihvonen, Susanna; Sokka-Isler, Tuulikki; Rantalaiho, Vappu
Publisher: Oxford University Press (OUP)
Publication year: 2025
Journal: Rheumatology Advances in Practice
Article number: rkaf139
Volume: 9
eISSN: 2514-1775
DOI: https://doi.org/10.1093/rap/rkaf139
Publication's open availability at the time of reporting: Open Access
Publication channel's open availability : Open Access publication channel
Web address : https://doi.org/10.1093/rap/rkaf139
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/505903441
Self-archived copy's licence: CC BY
Self-archived copy's version: Publisher`s PDF
Downloadable publication This is an electronic reprint of the original article. |  |
Funding information in the publication:
Vappu Rantalaiho received a personal grant for the expenses of the research group from the Competitive State Research Financing of the Expert Responsibility Area of Kanta-Häme Central Hospital and of the Wellbeing Services County of Pirkanmaa.
P.M. has received travel reimbursement from Abbvie, Orion Pharma and Boehringer Ingelheim. L.K. has received a personal grant from State Research Funding of Wellbeing Services County of South-West Finland, has a relationship including consulting and advisory with Galapagos, a relationship including consulting or advisory and speaking and lecture fees with Jannsen-Cilag, Pfizer and UCB, and has received speaking and lecture fees from Abbvie, Boehringer Ingelheim, Lilly and Medac. S.S. has received travel reimbursement from Pfizer, Novartis, and Medac. TS-I has received speaking and lecture fees from Abbvie, Lipum, Pfizer, Nordic Medicine and UCB, and has received grants from Amgen and Nordic Pharma. V.R. has received funding grants from Competitive State Research Financing of the Expert Responsibility Area of Kanta-Häme Central Hospital and of the Wellbeing Services County of Pirkanmaa, and Wilhelm and Else Stockmanns Foundation, and reports speaking and lecture fees from Novartis, Viatris, Abbvie, BMS, Johnson & Johnson, Medac and is a board member of Lilly. The remaining authors have declared no conflicts of interest.
